-
Featured
Medical Grand Rounds: COVID-19: Public Health and Scientific Challenges Featuring Dr. Anthony Fauci
On September 10, 2020, the Department of Medicine held a virtual Grand Rounds on COVID-19. Anthony S. Fauci, MD, National Institute of Allergy and Infectious Diseases (NIAID) director, spoke to the Boston medical community about COVID-19 public health and scientific challenges.
-
Featured
Preprint Data from RECOVERY Trial Show Mortality Benefit of Dexamethasone in COVID-19
The new standard of care is to consider dexamethasone for COVID-19 patients who are on oxygen or have hypoxemic respiratory failure.
-
Featured
Using Chloroquine to Treat COVID-19: Q&A with Raghu Chivukula, MD, PhD
Raghu Chivukula, MD, PhD, a physician-scientist in the Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital, explains what is currently known about chloroquine and its use to treat COVID-19 patients.
-
Teaching Resiliency to Help Health Care Professionals Cope: Q&A with Daphne J. Holt, MD, PhD
In this Q&A, Daphne J. Holt, MD, PhD, teaches skills for dealing with the overwhelming stress on health care workers during the pandemic and discusses how learning resiliency through online training can help them manage their mental health during this stressful time.
-
Heartburn & COVID-19: A Q&A With Kyle Staller, MD, MPH, on Proton Pump Inhibitors and Patient Risk
Recent headlines highlight survey findings indicating an increased risk of COVID-19 among Proton Pump Inhibitors users. In this Q&A, Kyle Staller, MD, MPH, disambiguates fact from hyperbole about the COVID-19–heartburn connection.
-
COVID-19 Simulator Informs Local Policymaking: Q&A with Jagpreet Chhatwal, PhD
The COVID-19 Simulator was launched in April 2020 to help health policymakers and practitioners make decisions regarding policy and strategy related to the novel coronavirus pandemic. The new tools further provide insights into local-level COVID-19 outbreaks and how far are we from reaching herd immunity.
COVID-19 contributors
-
Boris D. Juelg, MD, PhD
Attending Physician, Division of Infectious Diseases, Massachusetts General Hospital, Assistant Professor, Harvard Medical School
Recent Article
Favipiravir to Treat COVID-19: Q&A with Boris Juelg, MD, PhD
-
Bryan Hayes, PharmD, DABAT, FAACT, FASHP
Assistant Professor of Emergency Medicine, Harvard Medical School, Senior Attending Pharmacist, Emergency Medicine and Toxicology, Massachusetts General Hospital
Recent Article
The Use of NSAIDs in COVID-19 Patients: Q&A with Bryan D. Hayes, PharmD -
Charles Corey Hardin, MD, PhD
Physician, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School, Physician Investigator, Pulmonary, Mass General Research Institute
Recent Article
Commentary: Widely Reported Study of Therapeutic Anticoagulation for COVID-19 Has Serious Flaws
-
Elizabeth Louise Hohmann, MD
Staff Physician, Infectious Diseases Division, Massachusetts General Hospital, Chair and Physician Director, Partners Human Research Committees
Recent Article
Encapsulated Fecal Microbiota Transplantation Alters Gut Microbiome in Adults with Obesity -
Elizabeth M. Van Cott, MD
Director, Coagulation Laboratory, Massachusetts General Hospital, Professor of Pathology, Harvard Medical School
Recent Article
Pronounced Elevation of Factor V in Severe COVID-19 Is Associated with Venous Thromboembolism -
Erica Seiguer Shenoy, MD, PhD
Associate Physician, Massachusetts General Hospital, Associate Chief of the Infection Control Unit, Massachusetts General Hospital
Recent Article
What Is a Superspreader Event?
-
Galit Alter, PhD
Principal Investigator, Ragon Institute, Massachusetts General Hospital, Samana Cay MGH Research Scholar
Recent Article
MGH Research Scholars Respond to COVID-19
-
George A. Alba, MD
Pulmonary and Critical Care Physician, Instructor of Medicine at Harvard Medical School
Recent Article
The CORE Clinic and Post-ICU Care: Q&A with Leo Ginns, MD, and George Alba, MD
-
Hanny Al-Samkari, MD
Hematologist
Recent Article
Prothrombin Fragment 1.2 Predicts Thrombosis in Hospitalized Patients with COVID-19
-
Ilona T. Goldfarb, MD
Maternal Fetal Medicine Specialist
Recent Article
Aggregated Data Can Mask COVID-19 Rates in Vulnerable Communities
-
Katrina A. Armstrong, MD
Physician-in-Chief, Department of Medicine, Massachusetts General Hospital
Recent Article
Medical Grand Rounds: Safe Voting in a Pandemic: Challenges, Innovations and the Role of Health Care Professionals
-
Lorenzo Berra, MD
Medical Director, Respiratory Care, Massachusetts General Hospital
Recent Article
Case Series: Inhaled Nitric Oxide for Pregnant Patients with Severe or Critical COVID-19
-
Louise C. Ivers, MD
Executive Director of the Mass General Center for Global Health, Associate Physician in the Division of Infectious Diseases
Recent Article
Medical Grand Rounds: COVID-19 in Low-Resourced Settings—Reaching for Global Health Equity -
Rachel P. Rosovsky, MD
Hematologist, PERT Executive Committee Member
Recent Article
Prothrombin Fragment 1.2 Predicts Thrombosis in Hospitalized Patients with COVID-19
-
Raghu Chivukula, MD, PhD
Physician-Scientist, Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital
Recent Article
Identification of Novel Bronchiectasis Syndrome Has Implications for Other Respiratory Diseases
Pulmonary and Critical Care Medicine
The Division of Pulmonary and Critical Care Medicine at Massachusetts General Hospital provides comprehensive care for the full range of respiratory conditions and diseases.Related Links
